Cybin UK Ltd
7Patents
7Active
7Granted
57Portfolio score
Filing activity: Jun 2, 2020 → Mar 31, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12076311B2 | Therapeutic compositions comprising deuterated or partially deuterated N,N-dimethyltryptamine compounds | Chemistry; Metallurgy | 0 | Active |
| US12343327B2 | Injectable formulations | Human Necessities | 0 | Active |
| US12318477B2 | Injectable and inhalable formulations | Human Necessities | 0 | Active |
| US12084417B2 | Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses | Chemistry; Metallurgy | 0 | Active |
| US12042564B2 | Therapeutic solid dosage forms | Chemistry; Metallurgy | 0 | Active |
| US12157723B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US12251371B2 | Deuterated or partially deuterated N,N-dimethyltryptamine compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.